2009 washington state biomedical device summit: medical device industry outlook
TRANSCRIPT
2009 Washington State Biomedical Device Summit:
Medical Device Industry Outlook
Venkat Rajan
June 23rd. 2009
2
Industry Overview
Economic Impact
Hospital Focus Group
Impact of Proposed Health Policy Changes
Technologies of Focus
Focus Points
36/23/2009
Markets Covered by Frost & Sullivan Medical Device Team
Cardiovascular Devices
Orthopedic Devices
General Surgery
Endoscopy
Neurology Devices
Urology and Gynecology
Ophthalmic Equipment
Cosmetics and Aesthetics
Hearing and Audiology
Wound Care and Management
Respiratory and Anesthesia Equipment
Disinfection and Sterilization
Infusion Systems
Mobility Aids
46/23/2009
Innovations in diverse device markets propels growth as rapid diagnostics and therapeutic advances reshape demand.
Fragmented Patient Flow
From...
InvasiveInvasive Diagnostic & Treatment
Provider Centric Focus
Hospital TreatmentHospital Treatment Monitoring
One Size Fits All Approach
Therapeutics/Diagnostics/Devices
Therapeutics/Diagnostics/Devices
Tools
Treating SicknessTreating Sickness Objective
...To
Integrated & Automated
Less Invasive, Preventive, Image Based
Patient Centric
Out-of-hospital Treatment
Personalized Medicine
“Theranostics”
Preventing Sickness – “Wellness”
Paradigm Shift in Healthcare system …
56/23/2009
Industry FundamentalsInvestment Analysis
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
0.0% 5.0% 10.0% 15.0% 20.0%
Historical Growth Rate (2003-2006)
Pro
ject
ed G
row
th R
ate
(2006-2
013)
Cardiovascular Orthopedic EndoscopyDisinfection and Sterilization Hearing and Audiology Cosmetics and AestheticsWound Care and Management Infusion Pumps Mobility AidsGeneral Surgery Ophthalmic Respiratory and Anesthesia Urology Neurology
Historical CAGR: 9.3 %
Future CAGR: 8.9 %
Common Size Analysis Fixed Cost Analysis Ratio Analysis
66/23/2009
Financial AnalysisFinancial Analysis
Common Size Analysis Fixed Cost Analysis Ratio Analysis
Source: Frost & Sullivan
0%
20%
40%
60%
80%
100%
Perc
ent
of Fi
xed C
ost
s
2002 2003 2004 2005 2006
Years
Depreciation & Amortization Research & Development Salaries
Corporate Expense Rent/Leases Debt Financing (Income)
Pension Expense (Income)
Percent Break-up of Fixed Costs
76/23/2009
Financial AnalysisFinancial Analysis
Common Size Analysis Fixed Cost Analysis Ratio Analysis
Segment Gross
Profit
Margin
Operatin
g Profit
Margin
Net
Profit
Margin
R&D to
Sales
SGA to
Sales
Year 2006 (%) (%) (%) (%) (%)
Urology 78.6 19.4 9.6 8.2 39.9
Durable Medical Equipment 40.0 7.3 2.0 2.1 24.0
Orthopaedic 70.9 24.9 18.1 5.6 42.1
Cardiovascular 72.9 4.9 (1.7) 11.5 33.8
Ophthalmology 68.1 22.7 17.3 9.5 34.1
Laser 60.4 14.9 16.2 10.2 35.2
Respiratory 56.5 17.2 11.6 5.6 32.7
Medical Devices Industry 63.1 15.1 9.2 7.9 32.8
86/23/2009
Market Overview- Industry Sectors
Market Sectors of Stability• Cardiovascular
• Consumables
• Next Generation Treatments (Improve Clinical Efficiency, Reduce Costs)
• Infection Control
Market Sectors at Risk• Cosmetic procedures (implants, eye treatments, hair removal)
• Orthopedic Reconstruction
• Sports medicine treatments
• Orthodontics
• Capital Equipment (Energy Based Surgical Equipment, Robot Assisted Surgery, External Beam Radiotherapy)
96/23/2009
9
Increasing Financial Stress Affecting Health Of Hospitals
Decrease in patient care volumes as elective and non-critical procedures requiring self pay get postponed
Limited funding and high interest rates have made hospitals apprehensive about the uptake of new expensive technologies`
Increasing unemployment accompanied by loss of employer sponsored insurance attributes to rise in number of uninsured patients
Patients unable to afford for treatment tend to put-off care till conditions worsen leading to much expensive care
106/23/2009
0
10
20
30
40
50
60
70
80
90
Val
ue ($
Bill
ions
)
2000 2001 2002 2003 2004 2005 2006 2007 2008
Yea r
M&A Ac tivity MedT ec h S ec tor, 2000-2008
Investments Could Affect the Development of Next Generation Technologies
As with other sectors, investment money tight for startups
• No med tech IPOs since early 2008, None in 2009
• Med Tech VC Funding: $2.8 2008 Billion, $3.3 Billion 2007 Source Ernst & Young
• MedTech Overall financing: $4.6 billion 2008, $7.31 Billion 2007Source Ernst & Young
• Cost-to-market may be prohibitive for smaller emerging companies
• Low-risk products with quicker ROI and products outside stringent regulatory processes will be favored
• Continued investment in late stage entities preferred over new companies
• Consolidation and M&A expected to pick up midyear
116/23/2009
Increased Dependency on Third Parties
-Outsourcing• Companies turn to CRO’s and CMO’s for product development and manufacturing.
-Increase in influence of third party entities• Increased reprocessing of medical devices is expected
• GPOs and large volume purchasing will increase pressures on vendors
-Outside Market Entrants Looking to Healthcare for Growth• Electronic Chip Manufacturers
• Materials Science
• HCIT Services
126/23/2009
Market Strategies- Product Bundling, Exclusive Contracts
Economic Meltdown
Economies of Scale
Product Bundling,
Product Lining,Family Branding
•Product bundling becomes more of a point of emphasis to get new products to market
•Increase in volume sales even if the margins are reduced.
•Improve Brand Loyalty
•Large companies with broad product portfolio tend to bundle products to increase sales
•Smaller companies tend to tie up with complementary products to enhance market presence
136/23/2009
AHA Study Illustrates Hospital Concerns
A recent survey of hospital CEOs conducted by the American Hospital Association (November 2008) indicates that fewer patients are seeking hospital care, in particular elective procedures, and those seeking care are requiring more financial assistance. The report also states that hospitals, due to the difficulty in obtaining credit, may delay equipment purchases.
• Hospital spending on cap projects• 82% have put facilities projects on hold
• 65% have put clinical projects on hold
• 62% have put IT projects on hold
•96% of hospitals said postponement of capital projects was due to uncertainty about future economic conditions
•84% said a decline in operating performance contributed to this decision
•A majority of hospitals reported putting 50% or more of their capital budget on hold
146/23/2009
What we are Hearing……… Declines in Demand for Services
Number of elective surgeries has already dropped
• according to several hospital executives who point to recent internal tracking data as evidence
How long will it last and how deep will it go?
Actions to prevent a more serious erosion of revenue
• price increases• introduction of procedures new to the hospital (to
increase competitiveness and revenues)• actively marketing for new patients• outsourcing
“We have already seen our volume decrease for these procedures. The real question is to what extent will the economy delay these procedures and for how long.”
“We believe that there will be a slight down turn on planned procedure[s] [and] a major on elective.”
“Elective procedures have decreased slightly. As people lose their jobs, we expect there to be more self-pay patients and more patients deferring elective procedures.”
156/23/2009
What we are Hearing……… Hospitals Are Taking Immediate Action
Budget Reductions Just a Stop Gap
“[Our] operating budget has been reduced by about 33% versus 2007.”
“[W]e cut 20-23% in 2009 budget. Staff was cut by 10%, we laid off 10% of staff.”
Reductions in operating budgets and in capital spending budgets – Majority of the interviewed Hospital Executives
“We are holding on all non essential capital. Essentially no capital for new services or service expansion, just capital for replacement equipment.”
Have reduced or are selectively managing capital spending – For those yet to make operating budget cuts
“We have reduced operating budgets but may actually increase our capital budget over 2008. The reason for an increase in the capital budget is that most of the capital equipment is very old and is in need of replacement.”
No choice but to increase capex– Hospitals with aging or outdated equipment due for replacement
166/23/2009
Hospitals Are Taking Immediate Action
Creative Cost Saving and New Financial Measures• Consolidating campuses or departments, consolidating vendors, tracking physicians
• Eliminate service redundancy• Save on operating expenses• Measure individual physician profitability
“We reduced our operating overhead by putting our OB and PEDS beds in [suspension] at one of our campuses. As a result we have eliminated duplication of services in at least eight different areas and reduced our payroll expenses by about 40%...”
“Looking at different suppliers to reduce costs.”
Not all areas are affected• Especially if they are revenue generating• Emergency rooms have not generally been affected by budget cuts
“Our ER has been unaffected by our budget cuts since 90% of our admissions are generated thru the ER.”
“We will also begin to look at the physician level to determine which physicians make a procedure profitable vs. not profitable.”
“The current economy is actually increasing our admissions levels because there are more patients using our ER as their primary care physician, and because more members of the medical staff are sending their patients after hours to our ER for service.”
176/23/2009
What we are Hearing……… Hospitals Changing Approach to Capital Expenditures
Plans to alter capital expenditures for 2009• Majority of interviewed Hospital Executives• In response to already experienced or anticipated revenue shortfalls• Planned capital expenditure changes differ from one hospital to another• Most common changes would be:
• to eliminate all capital expenditures entirely• to reduce only non-essential capital purchases• to take a disciplined investment approach to capital expenditures
“We have no large capital expenditures planned for 2009, due to slower economy and fewer expected patients.”
“We are planning to finish construction projects that are already in progress and to replace equipment that breaks down during the course of the year. Until the economy evens out we do not plan on purchasing new capital.”
“Proposals for new programs and services which require significant capital start up will be either deferred or more critically evaluated re: cost/benefit analysis before "go/no go" decisions are made.”
186/23/2009
Capex Alternatives Sought
“We normally purchase equipment but due to the economy, will look into leasing more.”
“We are considering more leasing in order to conserve cash.”
“Due to limited funds, some equipment which we acquire may be reconditioned rather than new. May also consider lease to own options in some cases.”
“…looking into leasing for the reason [that] we don’t have to put as much capital upfront and can spread smaller cost out over [the] fiscal year.”
Hospitals looking at alternatives to capex. Many will turn to leasing or refurbishment rather than purchasing
Hospitals that had never considered leasing in the past now expect to turn to this method to preserve capital
“We generally stay away from leasing equipment, but we may enter into more leases this year to conserve cash.”
Still, many respondents indicate that the operating budget will suffer more than the capex budget
“Operation budget will see more of a reduction [than capex]. Less patients, less staff.”
196/23/2009
What we are Hearing……… New Service Lines Offer Opportunity
Development of New Service Lines Increases • Strategies employed by many hospitals to compensate for revenue decreases elsewhere in the business:
• Development of new service lines• Overall upgrade of capabilities• 9 of 11 Materials Managers reported growth within their hospitals – development of new
service lines and expanding facilities
“We have several business development initiatives which are being implemented to recruit new physicians, develop new lines of business and increase the number of more profitable payer groups of patients.”
“We are in the process right now of upgrading our EP labs and adding one cath lab. This is one of our most profitable product lines so we place a strong emphasis on new technology in the cardiac arena.”
“We are adding a cancer center. We feel that will benefit us in terms of additional revenue and in terms of maintaining our status as first class medical center.”
206/23/2009
What we are Hearing………Materials Managers
--Hospital Materials Managers
The downturn is affecting all of our hospitals. Census is down, elective surgeries are down, financing is much more difficult to obtain and scrutiny by lenders has increased according to our Corp CFO. We will have more ER patients who cannot pay with California unemployment at 10% The state is holding back/delaying payment of Medical as well. So we must watch our cash. We have always kept our operations lean, so far we have not downsized.
Infection Control has not been be affected yet. Obviously with the attention on hospital infections from payers, we are attempting to
mitigate the occurrence of those infections in order to maintain our reimbursement.
216/23/2009
Healthcare Policy- Proposed Changes
-Pillars of the Proposed Obama HC Plan
• Increased Affordability and Access to Coverage
• Improved Services and Quality
• Cost Control
• Focus on Wellness and Prevention
-Proposed Strategies
• Increase Options for Insurance Coverage
• Comparative Effectiveness Programs
• Cost Control
• Computerize Health Records
226/23/2009
Stimulus Plan Provisions
-HC Facility Construction Renovations
-$3.75 B in construction of new DoD medical facilities
-$445 M to renovations for existing DoD medical facilities
-$950 M to complete repairs and upgrades to VA facilities
-$1B to complete renovations and modernize renovate primary care clinics
-$550 M to improve Indian Health Service facilities
-Investment in HC
-$ 20 B to computerize health records
-$3B to improve wellness and preventative medicine programs
-$500M to help community care facilities pay for care of uninsured patients
-$600M to invest in training of primary care providers
-Expand Insurance Coverage
-$30.3 B to extend COBRA healthcare for unemployed
-Provides 100 percent federal funding through 2010 for optional State Medicaid coverage of individuals (and their dependents) who are receiving unemployment benefits or have exhausted those benefits and have no health insurance coverage.
236/23/2009
Healthcare Policy- Implications for Medical Device Manufacturers
-Price Control/Pricing Transparency
-Currently Prices are Negotiated between Manufacturers and Hospitals and
Distributors (variation up to 25% of ASP for certain technologies).
-Pricing Transparency Expected to Reduce Overall Costs Affect Margins
-Cost Effectiveness Programs
-Implemented through Agency for Healthcare Research and Quality (AHRQ),
National Institute of Health (NIH), Health and Human Services (HHS)
- Evaluate Clinical and Cost Effectiveness of various products and treatments
-$1.1Billion in Stimulus funds to conduct comparative effectiveness studies.
$400 M HHS, $300 M AHRQ, $400 M NIH
- Industry Taking a Cautious Wait and See Approach Time to be Proactive
246/23/2009
20 Medical Device Technologies Changing Healthcare
STENTS
CAPSULE ENDOSCOP
NEUROSTIMULATION
JOINT REPLACEMENT
NEURAL INTERFACE SYSTEMS
VENTRICULAR ASSIST DEVICES
TOTAL DISC REPLACEMENT
MEDICAL ROBOTICS
PERCUTANEOUS AORTIC VALVE
BRONCHIAL THERMOPLASTY
NEGATIVE PRESSURE WOUND THERAPY
NATURAL ORIFICE TRANSLUMAIL
ENDOSCOPY
THORACIC ENDOGRAFTING
ENGINEERED CARTILAGE REPAIR
PRODUCTS
MUSCULOSKELETAL GROWTH FACTORS
SITE SPECFIC DRUG DELIVERY
REMOTE REPORTING IMPLANTABLE
DEVICES
BARIATRIC SURGERY
BIONIC LIMBS
CARDIAC ABLATION
256/23/2009
Combination Devices Are A Step Towards The Integration Of The Healthcare Sector In The Future
• It is believed that 30% of new products under development are combination
products of medical devices embedded with pharmaceutical or biologics
components.
• The combination products market in 2009 is estimated to be worth $9.5 Billion.
Combine Diagnosis &
treatment = Cost effective
& less time consuming
Combine Diagnosis &
treatment = Cost effective
& less time consuming
Interventional devices
are used to treat the complexities
Interventional devices
are used to treat the complexities
Interventional Diagnostics
Methods
Interventional Diagnostics
Methods
DiagnosisDiagnosis TreatmentTreatment CombinationCombination
266/23/20092626
NOTES: A revolutionary surgical approach that uses the bodies natural orifices: mouth, anus, and vagina as entry points and aids in minimizing pain, scarring, recovery time, while circumventing complications associated with highly invasive surgery or laparoscopic procedures
Minimizing body trauma and improving cosmesis makes NOTES a highly regarded technology that is gaining a lot of traction in recent times
NOTES
Requirements for Effective
Realization
Natural Orifice Transluminal Endoscopic Surgery (NOTES) Fuelling The Transformation In Laproscopic Surgery
276/23/2009
Impact of Current Economic Situation(N=103)
10%
10%
9%
15%
17%
17%
14%
17%
27%
37%
26%
20%
31%
26%
24%
0% 20% 40% 60% 80% 100%
Upgrading existingproducts/technologies
Purchasing newproducts/technologies
Replacing existingproducts/technologies
Positive Impact - 5 4 No Impact - 3 2 Negative Impact - 1
Source: Frost & Sullivan Q21. What impact do you foresee the current economic climate having on your institution in terms of the following situations?
Upgrading of existing products / technologies is foreseen as being very negatively impacted by the economy by 27 percent of Electrophysiologists. Purchasing of new products / technologies is foreseen to be very negatively impacted by the economy by 37 percent of Electrophysiologists, and 26 percent foresee replacing existing products / technologies as being very negatively affected.
Impact of Current Economic Situation(N=103)
10%
10%
9%
15%
17%
17%
14%
17%
27%
37%
26%
20%
24%
26%
31%
0% 20% 40% 60% 80% 100%
Upgrading existingproducts/technologies
Purchasing newproducts/technologies
Replacing existingproducts/technologies
Positive Impact - 5 4 No Impact - 3 2 Negative Impact - 1
Snapshot: Catheter Ablation Market Expansion
286/23/2009
Expected Changes in Catheter Ablation Procedures within the Next 12 Months
17%
79%
21%
86%
14%
83%
0% 20% 40% 60% 80% 100%
Increase
Stay thesame
Total Sample (N=103)
100 or less Catheter Ablations performed per year (N=52)
101 or more Catheter Ablations performed per year (N=51)
Q13a. How do you expect the number of catheter ablation procedures in your practice to change within the next 12 months? Q13b. What percentage of (RESTORE Q.13A RESPONSE) change are you expecting in the number of catheter ablation procedures at your facility over the next 12 months?
Source: Frost & Sullivan
Snapshot: Catheter Ablation Market Expansion
Expected Increase in Catheter Ablation Procedures in the Next 12 Months
76%
22%
1%
63%
37%
89%
9%
2%
0%
20%
40%
60%
80%
100%
1-25% 26-50% 100%
Total Sample (N=85)
100 or less Catheter Ablations performed per year (N=41#)
101 or more Catheter Ablations performed per year (N=44#)
Overall, eighty-three percent of Electrophysiologists expect catheter ablations to increase over the next twelve months. Of those, seventy-six percent expect their catheter ablations to increase between 1 and 25%.
Source: Frost & SullivanNote: # indicates small sample; sample size does not support actionable analysis.
296/23/2009
Awareness FDA Panel's Recommendation for Treatment of Symptomatic Paroxymal Atrial
Fibrillation
41%
54%
46%
65%
35%
59%
0% 20% 40% 60% 80%
Yes
No
Total Sample (N=103)100 or less Catheter Ablations performed per year (N=52)101 or more Catheter Ablations performed per year (N=51)
Q14: Are you aware of the FDA Panel’s first recommendation for pre-market approval (PMA, effective November, 2008) of a system used for treatment of symptomatic paroxysmal Atrial Fibrillation?Q14A: What impact will the FDA Panel’s first recommendation for pre-market approval (PMA, effective November, 2008) of a system used for treatment of symptomatic paroxysmal Atrial Fibrillation have on your practice? Source: Frost & Sullivan
Expected Impact of FDA Panel's Recommendation on Symptomatic Atrial
Fibrillation on Practice
7%
36%33%
25%
7%
50%
21% 21%
6%
24%
42%
27%
0%
20%
40%
60%
Significantincrease
(>25%) in thenumber of
AFib ablationreferrals
Moderateincrease (16%- 25%) in thenumber of
AFib ablationreferrals
Limitedincrease (1%-
15%) in thenumber of
AFib ablationreferrals
No impact(0%) on thenumber of
AFib ablationreferrals
Total Sample (N=61)
100 or less Catheter Ablations performed per year (N=28#)
101 or more Catheter Ablations performed per year (N=33#)
Fifty-nine percent of Electrophysiologists are aware of the FDA Panel’s recommendation for pre-market approval of a system used for treatment of symptomatic paroxysmal Atrial Fibrillation. One-third of respondents expect that the recommendation will result in a moderate (16-25%) increase in the number of AFib ablation referrals.
Note: # indicates small sample; sample size does not support actionable analysis.
Snapshot: Catheter Ablation Market Expansion
306/23/2009
For Additional Information
For Additional Information
Jake Wengroff, Global DirectorCorporate CommunicationsNorth America (210) [email protected]
Venkat RajanIndustry ManagerMedical Devices(210) [email protected]
Mona PatelResearch DirectorHealthcare & Life Sciences(650) [email protected]